Prebuilt Receptor Library Speeds Personalized T-Cell Therapy

Using a library of ready-made T-cell receptors targeting recurring mutations in TP53, clinicians have developed a personalized autologous T-cell therapy that skips the usual months of bespoke receptor hunting and has produced responses lasting 6 to 19 months in early clinical testing.